Position in ABBV
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$33,865,459
+$6,635,929 QoQ
Shares Held
134,579
+7.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#453
of 4,153 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEDGE CAPITAL MANAGEMENT L L P/NC holds $67,797,573 across 8 Drug Manufacturers - General names. ABBV ranks #1 (50.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
134,579 | $33,865,459 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
528,057 | $30,426,644 | |
| 3 | JNJ |
Johnson & Johnson
|
4,295 | $1,090,801 | |
| 4 | LLY |
ELI LILLY & Co
|
764 | $916,364 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,873 | $626,180 | |
| 6 | PFE |
Pfizer Inc
|
13,423 | $323,225 | |
| 7 | AMGN |
Amgen Inc
|
840 | $304,180 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,937 | $244,720 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,865,459 | 134,579 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $27,229,530 | 125,199 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $28,273,352 | 123,740 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $30,044,398 | 129,759 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $30,588,691 | 164,792 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $33,340,079 | 159,126 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $28,573,982 | 160,799 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $32,495,728 | 164,552 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $36,437,537 | 212,439 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $39,813,979 | 218,638 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $31,918,396 | 205,965 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $31,916,727 | 214,120 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $30,800,894 | 228,612 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $37,972,611 | 238,267 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $40,057,139 | 247,863 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $34,362,457 | 256,035 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $37,907,559 | 247,503 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $36,385,265 | 224,448 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $37,569,979 | 277,474 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $29,256,177 | 271,217 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $32,009,134 | 284,172 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $31,679,673 | 292,734 | Shares | Sole | 2021-04-12 | |
| 2020-06-30 | $388,301 | 3,955 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $266,360 | 3,496 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||